๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

DNA topoisomerase II mutations and resistance to anti-tumor drugs

โœ Scribed by Yegor S. Vassetzky; Gian-Carlo Alghisi; Susan M. Gasser

Book ID
102758379
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
856 KB
Volume
17
Category
Article
ISSN
0265-9247

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

High antineoplastic activity of new hete
High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs
โœ Hermann Lage; Esin Aki-Sener; Ismail Yalcin ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 237 KB

## Abstract Twenty previously synthesized fused heterocyclic DNAโ€topoisomerase II (Topo II)โ€inhibiting compounds were investigated for their potential efficacy in various human cancer cell lines that were derived from different tumor entities. Moreover, different multidrugโ€resistant variants of the

Cytotoxicity, apoptosis induction and do
Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells
โœ Ze-Hong Miao; Tao Tang; Yi-Xiang Zhang; Jin-Sheng Zhang; Jian Ding ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 332 KB ๐Ÿ‘ 1 views

## Abstract Salvicine, a novel topoisomerase II inhibitor and a diterpenoid quinone compound, exerts potent __in vitro__ and __in vivo__ antitumor effects. In our study, we show that salvicine effectively kills multidrugโ€resistant (MDR) sublines, such as K562/A02, KB/VCR and MCFโ€7/ADR, and parental